Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview and Outlook Report 2019
Table of Contents
1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview 1
- 1.1 Product Overview and Scope of PARP (Poly ADP-Ribose Polymerase) Inhibitor 1
- 1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Types 2
- 1.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate Comparison by Types 2
- 1.2.2 Lynparza 4
- 1.2.3 Zejula 5
- 1.2.4 Rubraca 5
- 1.2.5 Talzenna 6
- 1.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Applications 6
- 1.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Comparison by Applications 6
- 1.3.2 Ovarian Cancer 8
- 1.3.3 Breast Cancer 9
- 1.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market by Regions 9
- 1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Regions 10
- 1.4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2014-2025) 11
- 1.4.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2014-2025) 11
- 1.4.4 Emerging Country PARP (Poly ADP-Ribose Polymerase) Inhibitor Status and Prospect (2014-2025) 12
- 1.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 13
- 1.5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2014-2025) 13
- 1.5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production (2014-2025) 14
2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competition by Manufacturers 15
- 2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Manufacturers (2014-2019) 15
- 2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Manufacturers (2014-2019) 17
- 2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price by Manufacturers (2014-2019) 19
- 2.4 Manufacturers PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Sites, Area Served, Product Types 21
- 2.5 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Competitive Situation and Trends 22
- 2.5.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Concentration Rate 22
- 2.5.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share of Top 3 and Top 5 Manufacturers 23
- 2.5.3 Mergers & Acquisitions, Expansion 24
3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production by Regions (2014-2019) 26
- 3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Regions 26
- 3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Regions (2014-2019) 28
- 3.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019) 30
- 3.4 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production 30
- 3.4.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019) 30
- 3.4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019) 31
- 3.5 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production 31
- 3.5.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate (2014-2019) 31
- 3.5.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price and Gross Margin (2014-2019) 32
4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Regions 33
- 4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption by Regions 33
- 4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019) 35
- 4.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019) 36
- 4.4 Emerging Country PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption (2014-2019) 37
5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue, Price Trend by Types 38
- 5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Types (2014-2019) 38
- 5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Types (2014-2019) 40
- 5.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price by Type (2014-2019) 42
- 5.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth by Type (2014-2019) 42
6 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Analysis by Applications 43
- 6.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Market Share by Applications (2014-2019) 43
- 6.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Growth Rate by Applications (2014-2019) 45
7 Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Key Manufacturers 46
- 7.1 AstraZeneca 46
- 7.1.1 Company Profile 46
- 7.1.2 Product Information 47
- 7.1.3 Production, Price and Revenue 47
- 7.2 Tesaro 48
- 7.2.1 Company Profile 48
- 7.2.2 Product Information 49
- 7.2.3 Production, Price and Revenue 49
- 7.3 Merck & Co 50
- 7.3.1 Company Profile 50
- 7.3.2 Product Information 51
- 7.3.3 Production, Price and Revenue 51
- 7.4 Clovis Oncology 51
- 7.4.1 Company Profile 51
- 7.4.2 Product Information 53
- 7.4.3 Production, Price and Revenue 53
- 7.5 Pfizer 54
- 7.5.1 Company Profile 54
- 7.5.2 Product Information 55
- 7.5.3 Production, Price and Revenue 56
8 PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Cost Analysis 57
- 8.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor R&D Cost Analysis 57
- 8.1.1 Clinical Phase Costs 58
- 8.1.2 Capitalized Costs 59
- 8.2 Proportion of Manufacturing Cost Structure 60
- 8.2.1 Raw Materials 60
- 8.2.2 Labor Cost 61
- 8.2.2.1 USA Labor Cost Analysis 61
- 8.2.2.2 Europe Labor Costs Analysis 63
- 8.2.2.3 Asia Labor Costs Analysis 65
- 8.2.3 Other Costs Analysis 67
- 8.2.3.1 USA Cost of Electricity Analysis 68
- 8.2.3.2 USA Water Cost Analysis 68
- 8.2.3.3 Europe Cost of Electricity Analysis 69
- 8.2.3.4 Europe Water Cost Analysis 70
- 8.2.3.5 China Cost of Electricity Analysis 70
- 8.2.3.6 China Water Cost Analysis 71
- 8.3 Manufacturing Process Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor 72
- 8.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industrial Chain Analysis 73
9 Marketing Channel, Distributors and Customers 74
- 9.1 Marketing Channel 74
- 9.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Distributors List 76
- 9.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Customers 79
10 Market Dynamics 81
- 10.1 Market Trends 81
- 10.2 Opportunities 83
- 10.2.1 Ovarian Cancer 84
- 10.2.2 Breast Cancer 87
- 10.3 Market Drivers 89
- 10.4 Challenges 90
- 10.5 Influence Factors 90
- 10.5.1 GDP for Major Regions 92
- 10.5.2 Population and Labor Considered for Forecast 94
- 10.5.3 Disposable Income Considered for Forecast 96
11 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Forecast 98
- 11.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast 98
- 11.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Growth Rate Forecast (2019-2025) 98
- 11.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate Forecast (2019-2025) 99
- 11.1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price and Trend Forecast (2019-2025) 100
- 11.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Forecast by Regions (2019-2025) 100
- 11.2.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025) 102
- 11.2.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue Forecast (2019-2025) 103
- 11.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast by Regions (2019-2025) 104
- 11.3.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025) 105
- 11.3.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025) 106
- 11.3.3 Emerging Country PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast (2019-2025) 107
- 11.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production, Revenue and Price Forecast by Type (2019-2025) 107
- 11.5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Consumption Forecast by Application (2019-2025) 110
12 Research Findings and Conclusion 111
13 Methodology and Data Source 112
- 13.1 Methodology/Research Approach 112
- 13.1.1 Research Programs/Design 112
- 13.1.2 Market Size Estimation 113
- 13.1.3 Market Breakdown and Data Triangulation 114
- 13.2 Data Source 116
- 13.2.1 Secondary Sources 116
- 13.2.2 Primary Sources 117
- 13.3 Author List 119
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market is valued at 1205 million US$ in 2018 is expected to reach 8800 million US$ by the end of 2025, growing at a CAGR of 32.8% during 2019-2025.
This report focuses on PARP (Poly ADP-Ribose Polymerase) Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall PARP (Poly ADP-Ribose Polymerase) Inhibitor market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Emerging Country.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
AstraZeneca
Tesaro
Merck & Co
Clovis Oncology
Pfizer
Segment by Regions
North America
Europe
Emerging Country
Rest of World
Segment by Type
Lynparza
Zejula
Rubraca
Talzenna
Other
Segment by Application
Ovarian Cancer
Breast Cancer
Other